Drug Markets/Methyldopa

Methyldopa

3 NDCs across 2 manufacturers|3 Generic,0 Brand

Methyldopa is used to treat hypertension, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved before 1982, and the first generic was approved Apr 18, 1985.

Methyldopa is available as 3 NDCs from 2 manufacturers (3 generic, 0 brand), with NADAC prices from $7.50 to $7.50 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

3

3G / 0B

Manufacturers

2

competing in market

Price Spread

$7.50 – $7.50

per EA

7d Activity

3 flat

avg +0.0% WoW · of 3 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

2 manufacturers producing METHYLDOPA

Drug Portfolio

3 NDCs total, 3 shown

Frequently Asked Questions

What is Methyldopa used to treat?

Methyldopa is used to treat hypertension, per the National Library of Medicine's MED-RT classification.

When did Methyldopa become available as a generic?

FDA approved the first generic Methyldopa (ANDA) on Apr 18, 1985.

How many Methyldopa products are on the market?

The Methyldopa drug market contains 3 NDCs from 2 manufacturers — 3 generic and 0 brand products.

What is the price range for Methyldopa?

NADAC reference prices for Methyldopa range from $7.4999 to $7.4999 per EA.

Which manufacturers make Methyldopa?

2 manufacturers list Methyldopa in NADAC. Ranked by number of NDCs, the largest are Chartwell RX LLC (2), Rising Pharma Holdings Inc. (1).